// App-Quantinova.ai

THU0180 (2017) : SYSTEMS BASED INVESTIGATION OF THE ANTI-IMMUNOGENIC POTENTIAL OF DMARDS FOR RHEUMATOID ARTHRITIS USING HUMAN PRIMARY CELL-BASED BIOMAP® PHENOTYPIC PROFILING

Researchers

Presenter

  • A. O'Mahony

Principal Investigators

  • E. Choy

Medical Centers

  • BioMAP Division, DiscoverX Corporation, South San Francisco, United States

  • Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • Oraprine

  • Cyclosporine eent

  • HWA-486

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved